BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Equibles//Investor Events//EN CALSCALE:GREGORIAN METHOD:PUBLISH NAME:Lyell Immunopharma\, Inc. (LYEL) investor events X-WR-CALNAME:Lyell Immunopharma\, Inc. (LYEL) investor events DESCRIPTION:Earnings calls and investor events for Lyell Immunopharma\, Inc . (LYEL)\, from Equibles. X-WR-CALDESC:Earnings calls and investor events for Lyell Immunopharma\, In c. (LYEL)\, from Equibles. REFRESH-INTERVAL;VALUE=DURATION:PT6H X-PUBLISHED-TTL:PT6H BEGIN:VEVENT UID:3813eaf7-fb81-4044-98ed-561903849813@equibles.com DTSTAMP:20260617T191031Z DTSTART;VALUE=DATE:20251112 DTEND;VALUE=DATE:20251113 SEQUENCE:0 STATUS:CANCELLED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Earnings Call\, FY2025 Q3 DESCRIPTION:No call was held: the company published its results without one . END:VEVENT BEGIN:VEVENT UID:770a5995-1fbe-4a81-be32-11c39a7bd709@equibles.com DTSTAMP:20260624T233125Z DTSTART;VALUE=DATE:20260223 DTEND;VALUE=DATE:20260224 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Lyell Immunopharma Ann ounces Participation in March Investor Conferences DESCRIPTION:Lyell Immunopharma Announces Participation in March Investor Co nferences\nThe start time has not been announced.\nWebcast: https://ir.lye ll.com/news-releases/news-release-details/lyell-immunopharma-announces-par ticipation-march-investor-0 END:VEVENT BEGIN:VEVENT UID:3ee4a360-1e48-4e90-9dda-a9e38e8b2302@equibles.com DTSTAMP:20260826T092150Z DTSTART:20260302T141000Z DTEND:20260302T151000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: TD Cowen 46th Annual H ealth Care Conference DESCRIPTION:TD Cowen 46th Annual Health Care Conference\nWebcast: https://e vent.summitcast.com/view/9z5g2VrV6e6rbCqQgDRoHA/guest_book?session_id=5e6F TfnjwupNyZfvVGRehc END:VEVENT BEGIN:VEVENT UID:fa09fd68-1f25-442e-8598-c69343913196@equibles.com DTSTAMP:20260826T092150Z DTSTART:20260309T140000Z DTEND:20260309T150000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Leerink Annual Global Healthcare Conference DESCRIPTION:Leerink Annual Global Healthcare Conference\nWebcast: https://e vent.summitcast.com/view/mT9poctHDNthc6b89WqVjf/guest_book?session_id=ifxA 4MvpnyWh945wcrLGKa END:VEVENT BEGIN:VEVENT UID:5f361853-dbec-46d2-8482-90181fb83150@equibles.com DTSTAMP:20260826T092150Z DTSTART:20260310T155500Z DTEND:20260310T165500Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Citizens Life Science Conference DESCRIPTION:Citizens Life Science Conference\nWebcast: https://event.summit cast.com/view/BuMiPNPtyHKimMF6k4AFMd/guest_book?session_id=QsNKtehWyst2wBE VyXKEcU END:VEVENT BEGIN:VEVENT UID:a950e003-36cb-4c9d-878e-058a2072373d@equibles.com DTSTAMP:20260617T191110Z DTSTART;VALUE=DATE:20260312 DTEND;VALUE=DATE:20260313 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Earnings Call\, FY2025 Q4 DESCRIPTION:The start time has not been announced.\nWebcast: https://ir.lye ll.com/news-releases/news-release-details/lyell-immunopharma-reports-q4-an d-full-year-2025-business-and URL:https://equibles.com/stocks/lyel/calls/2025-q4 END:VEVENT BEGIN:VEVENT UID:0f735449-2f40-4901-847c-63327a5b627d@equibles.com DTSTAMP:20260624T233125Z DTSTART;VALUE=DATE:20260407 DTEND;VALUE=DATE:20260408 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Lyell Immunopharma Ann ounces Participation in 25th Annual Needham Virtual Healthcare Conference DESCRIPTION:Lyell Immunopharma Announces Participation in 25th Annual Needh am Virtual Healthcare Conference\nThe start time has not been announced.\n Webcast: https://ir.lyell.com/news-releases/news-release-details/lyell-imm unopharma-announces-participation-25th-annual-needham END:VEVENT BEGIN:VEVENT UID:aead3d80-3481-49bf-be23-7bbebb3f0bf5@equibles.com DTSTAMP:20260826T092150Z DTSTART:20260414T150000Z DTEND:20260414T160000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: 25th Annual Needham Vi rtual Healthcare Conference DESCRIPTION:25th Annual Needham Virtual Healthcare Conference\nWebcast: htt ps://event.summitcast.com/view/cCMfZsH5ZqrwSNTwfC9JDv/kDAtqDSQBZ8vyawYQkt2 JD END:VEVENT BEGIN:VEVENT UID:6dad1e97-ab8e-4ec9-901a-ae8f1ba6b071@equibles.com DTSTAMP:20260624T233125Z DTSTART;VALUE=DATE:20260512 DTEND;VALUE=DATE:20260513 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Lyell Immunopharma Ann ounces Participation in May Investor Conferences DESCRIPTION:Lyell Immunopharma Announces Participation in May Investor Conf erences\nThe start time has not been announced.\nWebcast: https://ir.lyell .com/news-releases/news-release-details/lyell-immunopharma-announces-parti cipation-may-investor END:VEVENT BEGIN:VEVENT UID:767e75dd-9e26-4baa-a357-4752e9f53d0e@equibles.com DTSTAMP:20260826T092150Z DTSTART:20260519T150000Z DTEND:20260519T160000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: H.C. Wainwright 4th An nual BioConnect Investor Conference DESCRIPTION:H.C. Wainwright 4th Annual BioConnect Investor Conference\nWebc ast: https://ir.lyell.com/events/event-details/hc-wainwright-4th-annual-bi oconnect-investor-conference END:VEVENT BEGIN:VEVENT UID:2de21ff7-1d4f-4c22-882a-63181fca878c@equibles.com DTSTAMP:20260617T191049Z DTSTART:20260520T200000Z DTEND:20260520T210000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Earnings Call\, FY2026 Q1 DESCRIPTION:Webcast: https://event.summitcast.com/view/SScpdhHfwE8g9WsS8WcT ax/guest_book?session_id=jry8sjqbPzFMbkUTxbA2iN URL:https://equibles.com/stocks/lyel/calls/2026-q1 END:VEVENT BEGIN:VEVENT UID:b12154eb-400a-4be2-95e0-d2317576476b@equibles.com DTSTAMP:20260624T233125Z DTSTART;VALUE=DATE:20260601 DTEND;VALUE=DATE:20260602 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Lyell Immunopharma Ann ounces Participation in Goldman Sachs 47th Annual Global Healthcare Confer ence 2026 DESCRIPTION:Lyell Immunopharma Announces Participation in Goldman Sachs 47t h Annual Global Healthcare Conference 2026\nThe start time has not been an nounced.\nWebcast: https://ir.lyell.com/news-releases/news-release-details /lyell-immunopharma-announces-participation-goldman-sachs-47th END:VEVENT BEGIN:VEVENT UID:766b27a0-6fae-4d29-9da9-93e2f61d2327@equibles.com DTSTAMP:20260826T092150Z DTSTART:20260608T152000Z DTEND:20260608T162000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Goldman Sachs 47th Ann ual Global Healthcare Conference DESCRIPTION:Goldman Sachs 47th Annual Global Healthcare Conference\nWebcast : https://event.webcasts.com/starthere.jsp?ei=1764407&tp_key=cd9cad8011&tp _special=8 URL:https://equibles.com/stocks/lyel/events/766b27a0-6fae-4d29-9da9-93e2f61 d2327 END:VEVENT BEGIN:VEVENT UID:bcfe0599-7741-47f1-9fe4-92bd9a9fe434@equibles.com DTSTAMP:20260626T005542Z DTSTART;VALUE=DATE:20260625 DTEND;VALUE=DATE:20260626 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Lyell Immunopharma Ann ounces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Co nference DESCRIPTION:Lyell Immunopharma Announces Participation in H.C. Wainwright 4 th Annual Cell Therapy Virtual Conference\nThe start time has not been ann ounced.\nWebcast: https://ir.lyell.com/news-releases/news-release-details/ lyell-immunopharma-announces-participation-hc-wainwright-4th END:VEVENT BEGIN:VEVENT UID:b8c2cf9e-2233-460a-b27e-16dd0bbb7514@equibles.com DTSTAMP:20260826T092150Z DTSTART:20260630T173000Z DTEND:20260630T183000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: H.C. Wainwright 4th An nual Cell Therapy Virtual Conference DESCRIPTION:H.C. Wainwright 4th Annual Cell Therapy Virtual Conference\nWeb cast: https://ir.lyell.com/events/event-details/hc-wainwright-4th-annual-c ell-therapy-virtual-conference END:VEVENT BEGIN:VEVENT UID:b49a3662-1e11-4652-80f6-d4528cbf13f0@equibles.com DTSTAMP:20260808T131852Z DTSTART;VALUE=DATE:20260806 DTEND;VALUE=DATE:20260807 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Earnings Call\, FY2026 Q2 DESCRIPTION:The start time has not been announced.\nWebcast: https://ir.lye ll.com/news-releases/news-release-details/lyell-immunopharma-reports-busin ess-highlights-and-financial-12 URL:https://equibles.com/stocks/lyel/calls/2026-q2 END:VEVENT BEGIN:VEVENT UID:9638273a-3bcc-460a-af21-e20a7985609f@equibles.com DTSTAMP:20260919T153448Z DTSTART:20260915T180000Z DTEND:20260915T190000Z SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:Lyell Immunopharma\, Inc. (LYEL) Conference: Baird 2026 Global Heal thcare Conference DESCRIPTION:Baird 2026 Global Healthcare Conference\nWebcast: https://event .summitcast.com/view/ec9NeVzPhdriPTAJnHFkeS/guest_book?session_id=JpnT9boJ bvyrCfFKRa6yk9 URL:https://equibles.com/stocks/lyel/events/9638273a-3bcc-460a-af21-e20a798 5609f END:VEVENT END:VCALENDAR